1. Home
  2. ACHR vs TMDX Comparison

ACHR vs TMDX Comparison

Compare ACHR & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Archer Aviation Inc.

ACHR

Archer Aviation Inc.

HOLD

Current Price

$6.78

Market Cap

5.4B

Sector

Industrials

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$133.85

Market Cap

4.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACHR
TMDX
Founded
2018
1998
Country
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
4.6B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ACHR
TMDX
Price
$6.78
$133.85
Analyst Decision
Buy
Buy
Analyst Count
7
8
Target Price
$12.14
$144.25
AVG Volume (30 Days)
36.2M
720.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$38.73
Revenue Next Year
N/A
$20.55
P/E Ratio
N/A
$52.77
Revenue Growth
N/A
N/A
52 Week Low
$5.48
$62.07
52 Week High
$14.62
$156.00

Technical Indicators

Market Signals
Indicator
ACHR
TMDX
Relative Strength Index (RSI) 38.16 49.52
Support Level $6.61 $127.50
Resistance Level $7.57 $140.72
Average True Range (ATR) 0.40 6.95
MACD -0.05 -0.66
Stochastic Oscillator 22.45 35.01

Price Performance

Historical Comparison
ACHR
TMDX

About ACHR Archer Aviation Inc.

Archer Aviation Inc advances the benefits of sustainable air mobility. The company is engaged in designing and developing a fully electric vertical takeoff and landing eVTOL aircraft for use in UAM networks. It is creating an electric airline that moves people throughout cities in a quick, safe, sustainable, and cost-effective manner.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: